Advisor Group’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$33K Buy
1,020
+121
+13% +$3.44K ﹤0.01% 3671
2019
Q3
$22K Sell
899
-90
-9% -$2.57K ﹤0.01% 3889
2019
Q2
$29K Buy
989
+198
+25% +$5.78K ﹤0.01% 3720
2019
Q1
$22K Buy
791
+545
+222% +$16.6K ﹤0.01% 3925
2018
Q4
$8K Buy
+246
New +$7.66K ﹤0.01% 4301
2017
Q3
Sell
-850
Closed -$21K 4828
2017
Q2
$21K Buy
850
+600
+240% +$12.8K ﹤0.01% 3467
2017
Q1
$5K Hold
250
﹤0.01% 4094
2016
Q4
$5K Buy
+250
New +$4.53K ﹤0.01% 3914
2016
Q3
Sell
-92
Closed -$1K 4464
2016
Q2
$1K Buy
+92
New +$1.4K ﹤0.01% 4199

Other funds holding ATRC

Advisor Group's ATRC Position: Q4 2019 in Review

Advisor Group increased its AtriCure (ATRC) stake by 13% in Q4 2019, buying an estimated $3.44K and bringing the position to 1,020 shares worth $33K. The position accounts for ﹤0.01% of the portfolio, ranked #3671.

Advisor Group first reported a position in ATRC in Q2 2016 and has held it in 9 quarters since. 141 funds tracked by Wall St. Rank hold ATRC as of Q4 2019.

  • Advisor Group held 1,020 shares of AtriCure worth $33K as of Q4 2019.
  • Advisor Group bought 121 AtriCure shares in Q4 2019, an estimated $3.44K.
  • AtriCure made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #3671 holding.
  • Advisor Group first reported a position in AtriCure in Q2 2016 and has held it in 9 quarters since.
  • 141 funds tracked by Wall St. Rank held AtriCure as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.